Physician

Sarah E. Glorioso, M.D.

According to 2025 Medicare claims, Sarah Glorioso, M.D. (NPI: 1093916140) practices dermatology in the Shreveport-Bossier City, LA market, with the plurality of this provider's patient population coming from Bossier, LA. This provider's primary affiliated billing organization is WK DERMATOLOGY CLINIC (NPI: 1538372883; TIN: 208912920) and primary practice location at 71111-2180.

Glorioso's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,633 traditional Medicare patients, billed 13,271 HCPCS/CPT codes, and received $426,519 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 2,161 prescription claims across 697 beneficiaries totaling $1,412,699 in drug costs, led by Stelara (Ustekinumab). Open Payments data shows 53 records totaling $1,170. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $320,387 to $426,519. Similarly, Part D prescription costs have moved sharply higher in recent years, from $64,119 to $1,412,699. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,296	9,959	$320,387
2016	1,356	11,519	$361,666
2017	1,431	10,436	$309,416
2018	1,426	10,886	$351,655
2019	1,490	12,183	$348,832
2020	1,407	11,243	$345,626
2021	1,708	13,805	$475,194
2022	1,832	14,028	$486,808
2023	1,725	13,816	$454,954
2024	1,633	13,271	$426,519

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	353	976	$64,119
2016	415	1,303	$79,817
2017	449	1,349	$154,948
2018	454	1,367	$227,559
2019	515	1,595	$304,066
2020	532	1,951	$485,705
2021	663	2,041	$399,136
2022	706	2,131	$880,259
2023	633	1,924	$888,643
2024	697	2,161	$1,412,699

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	489	568	$75
11102	Biopsy of related skin growth, first growth	404	517	$60
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,142	1,601	$59
17000	Destruction of precancer skin growth, 1 growth	897	1,251	$36
17003	Destruction of precancer skin growth, 2-14 growths	758	6,628	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Stelara	Ustekinumab	12	952	$255,229
Tremfya	Guselkumab	18	924	$252,235
Cosentyx Unoready Pen	Secukinumab	15	420	$137,362
Humira(Cf) Pen	Adalimumab	15	420	$104,859
Dupixent Syringe	Dupilumab	26	728	$98,043

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	53	$1,170	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sarah E. Glorioso, M.D.?

Tedicare shows public-source Medicare data for Sarah E. Glorioso, M.D. (NPI 1093916140), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sarah E. Glorioso, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sarah E. Glorioso, M.D.?

Sarah E. Glorioso, M.D. is linked to WK DERMATOLOGY CLINIC (billing NPI 1538372883) in the available physician profile data.

Does Sarah E. Glorioso, M.D. have Open Payments data?

Sarah E. Glorioso, M.D. has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.